Ketamine as a Novel Psychopharmacotherapy for Eating Disorders: Evidence and Future Directions.
Brain sciences March 12, 2022 Anya Ragnhildstveit, Matthew Slayton, Laura Kate Jackson et al.
Eating disorders are serious psychiatric conditions with limited treatment options. Ketamine, a drug approved for treatment-resistant depression, is now being investigated for eating disorders. This review examines the evidence for ketamine in treating anorexia nervosa, bulimia nervosa, and binge eating disorder. Results are encouraging but limited to case reports on anorexia nervosa. More research is needed to determine ketamine's effectiveness across different eating disorder types, establish safety, and optimize dosing.